Literature DB >> 18391011

Characterization of fifty putative inclusion membrane proteins encoded in the Chlamydia trachomatis genome.

Zhongyu Li1, Chaoqun Chen, Ding Chen, Yimou Wu, Youmin Zhong, Guangming Zhong.   

Abstract

Although the Chlamydia trachomatis genome is predicted to encode 50 inclusion membrane proteins, only 18 have been experimentally localized in the inclusion membrane of C. trachomatis-infected cells. Using fusion proteins and anti-fusion protein antibodies, we have systematically evaluated all 50 putative inclusion membrane proteins for their localization in the infected cells, distribution patterns, and effects on subsequent chlamydial infection when expressed ectopically, as well as their immunogenicity during chlamydial infection in humans. Twenty-two of the 50 proteins were localized in the inclusion membrane, and 7 were detected inside the inclusions, while the location of the remaining 21 was not defined. Four (CT225, CT228, CT358, and CT440) of the 22 inclusion membrane-localized proteins were visualized in the inclusion membrane of Chlamydia-infected cells for the first time in the current study. The seven intra-inclusion-localized proteins were confirmed to be chlamydial organism proteins in a Western blot assay. Further characterization of the 50 proteins revealed that neither colocalization with host cell endoplasmic reticulum nor inhibition of subsequent chlamydial infection by ectopically expressed proteins correlated with the inclusion membrane localization. Interestingly, antibodies from women with C. trachomatis urogenital infection preferentially recognized proteins localized in the inclusion membrane, and the immunodominant regions were further mapped to the region predicted to be on the cytoplasmic side of the inclusion membrane. These observations suggest that most of the inclusion membrane-localized proteins are both expressed and immunogenic during C. trachomatis infection in humans and that the cytoplasmic exposure may enhance the immunogenicity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18391011      PMCID: PMC2423075          DOI: 10.1128/IAI.00010-08

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  62 in total

1.  Sigma28 RNA polymerase regulates hctB, a late developmental gene in Chlamydia.

Authors:  Hilda Hiu Yin Yu; Ming Tan
Journal:  Mol Microbiol       Date:  2003-10       Impact factor: 3.501

2.  Lymphogranuloma venereum: how to turn an endemic disease into an outbreak of a new disease? Start looking.

Authors:  Julius Schachter; Jeanne Moncada
Journal:  Sex Transm Dis       Date:  2005-06       Impact factor: 2.830

3.  Immunoaccessible peptide sequences of the major outer membrane protein from Chlamydia trachomatis serovar C.

Authors:  G M Zhong; R C Brunham
Journal:  Infect Immun       Date:  1990-10       Impact factor: 3.441

4.  Chlamydia-infected cells continue to undergo mitosis and resist induction of apoptosis.

Authors:  Whitney Greene; Yangming Xiao; Yanqing Huang; Grant McClarty; Guangming Zhong
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

5.  Chlamydia trachomatis infection inhibits both Bax and Bak activation induced by staurosporine.

Authors:  Yangming Xiao; Youmin Zhong; Whitney Greene; Feng Dong; Guangming Zhong
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

6.  Rab GTPases are recruited to chlamydial inclusions in both a species-dependent and species-independent manner.

Authors:  Kimberly A Rzomp; Luella D Scholtes; Benjamin J Briggs; Gary R Whittaker; Marci A Scidmore
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

7.  Activation of Raf/MEK/ERK/cPLA2 signaling pathway is essential for chlamydial acquisition of host glycerophospholipids.

Authors:  Heng Su; Grant McClarty; Feng Dong; Grant M Hatch; Zhixing K Pan; Guangming Zhong
Journal:  J Biol Chem       Date:  2003-12-15       Impact factor: 5.157

8.  Chlamydia trachomatis sigma28 recognizes the fliC promoter of Escherichia coli and responds to heat shock in chlamydiae.

Authors:  Li Shen; Maixiang Li; You-Xun Zhang
Journal:  Microbiology       Date:  2004-01       Impact factor: 2.777

9.  Pathogenesis of trachoma: the stimulus for inflammation.

Authors:  H R Taylor; S L Johnson; J Schachter; H D Caldwell; R A Prendergast
Journal:  J Immunol       Date:  1987-05-01       Impact factor: 5.422

10.  Chlamydial development is blocked in host cells transfected with Chlamydophila caviae incA.

Authors:  Damir Alzhanov; Jennifer Barnes; Dennis E Hruby; Daniel D Rockey
Journal:  BMC Microbiol       Date:  2004-07-01       Impact factor: 3.605

View more
  87 in total

1.  Protective immunity against mouse upper genital tract pathology correlates with high IFNγ but low IL-17 T cell and anti-secretion protein antibody responses induced by replicating chlamydial organisms in the airway.

Authors:  Chunxue Lu; Hao Zeng; Zhihong Li; Lei Lei; I-Tien Yeh; Yimou Wu; Guangming Zhong
Journal:  Vaccine       Date:  2011-11-10       Impact factor: 3.641

2.  Identification of Chlamydia trachomatis outer membrane complex proteins by differential proteomics.

Authors:  Xiaoyun Liu; Mary Afrane; David E Clemmer; Guangming Zhong; David E Nelson
Journal:  J Bacteriol       Date:  2010-03-26       Impact factor: 3.490

Review 3.  Genetic variation in Chlamydia trachomatis and their hosts: impact on disease severity and tissue tropism.

Authors:  Hossam Abdelsamed; Jan Peters; Gerald I Byrne
Journal:  Future Microbiol       Date:  2013-09       Impact factor: 3.165

4.  A Chlamydia trachomatis OmcB C-terminal fragment is released into the host cell cytoplasm and is immunogenic in humans.

Authors:  Manli Qi; Siqi Gong; Lei Lei; Quanzhong Liu; Guangming Zhong
Journal:  Infect Immun       Date:  2011-03-21       Impact factor: 3.441

5.  Impact of Active Metabolism on Chlamydia trachomatis Elementary Body Transcript Profile and Infectivity.

Authors:  Scott Grieshaber; Nicole Grieshaber; Hong Yang; Briana Baxter; Ted Hackstadt; Anders Omsland
Journal:  J Bacteriol       Date:  2018-06-25       Impact factor: 3.490

6.  A chlamydial type III-secreted effector protein (Tarp) is predominantly recognized by antibodies from humans infected with Chlamydia trachomatis and induces protective immunity against upper genital tract pathologies in mice.

Authors:  Jie Wang; Lili Chen; Fan Chen; Xiaoyun Zhang; Yingqian Zhang; Joel Baseman; Sondra Perdue; I-Tien Yeh; Rochelle Shain; Martin Holland; Robin Bailey; David Mabey; Ping Yu; Guangming Zhong
Journal:  Vaccine       Date:  2009-03-10       Impact factor: 3.641

7.  Quantitative proteomics reveals metabolic and pathogenic properties of Chlamydia trachomatis developmental forms.

Authors:  Hector A Saka; J Will Thompson; Yi-Shan Chen; Yadunanda Kumar; Laura G Dubois; M Arthur Moseley; Raphael H Valdivia
Journal:  Mol Microbiol       Date:  2011-11-07       Impact factor: 3.501

8.  Chlamydia trachomatis secretion of hypothetical protein CT622 into host cell cytoplasm via a secretion pathway that can be inhibited by the type III secretion system inhibitor compound 1.

Authors:  Siqi Gong; Lei Lei; Xiaotong Chang; Robert Belland; Guangming Zhong
Journal:  Microbiology (Reading)       Date:  2011-01-13       Impact factor: 2.777

9.  Absence of Specific Chlamydia trachomatis Inclusion Membrane Proteins Triggers Premature Inclusion Membrane Lysis and Host Cell Death.

Authors:  Mary M Weber; Jennifer L Lam; Cheryl A Dooley; Nicholas F Noriea; Bryan T Hansen; Forrest H Hoyt; Aaron B Carmody; Gail L Sturdevant; Ted Hackstadt
Journal:  Cell Rep       Date:  2017-05-16       Impact factor: 9.423

Review 10.  Acquisition of nutrients by Chlamydiae: unique challenges of living in an intracellular compartment.

Authors:  Hector Alex Saka; Raphael H Valdivia
Journal:  Curr Opin Microbiol       Date:  2009-12-16       Impact factor: 7.934

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.